國家衛生研究院 NHRI:Item 3990099045/11065
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907617      Online Users : 945
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11065


    Title: Quantification of urinary tryptophan metabolites and evaluation of their potential use as urothelial cancer biomarkers
    Authors: Li, LA;Luo, HL;Wang, CJ;Chiang, PH;Chiang, PH
    Contributors: National Institute of Environmental Health Sciences;Institute of Population Health Sciences
    Abstract: Patients with chronic kidney disease or renal insufficiency have increased risk of urothelial cancer. Increased excretion of tryptophan metabolites in the urine has been observed in renal-insufficient rats. Aberrant tryptophan metabolism may play a role in the development of urothelial cancer. To evaluate the relevance of tryptophan metabolism in urothelial cancer, we developed a LC-MS-MS method to simultaneously quantify five tryptophan metabolites as well as tryptophan in urine. Urine samples were cleaned up by on-line solid phase extraction before separation by C18-amide reversed-phase chromatography. The analytes were detected in positive ion multiple reaction monitoring (MRM) mode with a lower limit of quantification at 1 ng/ml. The relative standard deviation (RSD) for recovery and precision ranged between 3.10–7.65% and 1.80–9.33%, respectively. A preliminary study on 45 upper urinary tract cancer patients and 35 controls showed that cancer patients had higher levels of kynurenine and kynurenic acid in urine and elevated urinary kynurenine/tryptophan ratios. Although further studies are needed, our preliminary data suggest that tryptophan metabolites can be potential biomarkers for diagnosis and prognosis of urothelial cancer.
    Date: 2017-10
    Relation: Toxicology Letters. 2017 Oct;280:S299.
    Link to: http://dx.doi.org/10.1016/j.toxlet.2017.07.836
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0378-4274&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000425486700759
    Appears in Collections:[Lih-Ann Li] Conference Papers/Meeting Abstract
    [Po-Huang Chiang] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI000425486700759.pdf77KbAdobe PDF319View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback